HAMP and type 2 diabetes mellitus: Participants with Type 2 diabetes (n = 33) had significantly lower median hepcidin-25 levels (P < 0.05) and median hepcidin:ferritin ratio (P < 0.01) than weight-matched control subjects (n = 33).